TipRanks
INBIOGEN CO., Ltd. (KR:101140)
:101140
South Korea Market

INBIOGEN CO., Ltd. (101140) Ratios

― Followers

INBIOGEN CO., Ltd. Ratios

KR:101140's free cash flow for Q2 2026 was ₩-0.10. For the 2026 fiscal year, KR:101140's free cash flow was decreased by ₩ and operating cash flow was ₩-0.61. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.37 2.86 4.38 5.48 0.47
Quick Ratio
1.37 2.84 4.33 5.06 0.43
Cash Ratio
0.47 0.48 2.70 2.88 0.26
Solvency Ratio
-3.83 2.63 5.94 7.66 -3.16
Operating Cash Flow Ratio
-0.72 -2.98 -0.02 -0.50 -0.32
Short-Term Operating Cash Flow Coverage
-1.04 -11.11 0.00 0.00 -12.32
Net Current Asset Value
₩ 1.52B₩ 2.97B₩ 6.39B₩ 8.96B₩ -20.37B
Leverage Ratios
Debt-to-Assets Ratio
0.03 <0.01 <0.01 <0.01 0.01
Debt-to-Equity Ratio
0.03 <0.01 <0.01 <0.01 0.02
Debt-to-Capital Ratio
0.03 <0.01 <0.01 <0.01 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.04 1.01 1.02 1.02 1.36
Debt Service Coverage Ratio
1.50 -6.86 335.55 50.91 13.50
Interest Coverage Ratio
-27.73 -55.23 -118.66 -23.47 11.93
Debt to Market Cap
0.07 <0.01 0.00 0.00 0.02
Interest Debt Per Share
8.39K 124.08 94.76 85.62 1.51K
Net Debt to EBITDA
0.31 -0.07 -0.28 -0.41 -0.17
Profitability Margins
Gross Profit Margin
-10.71%-9.12%9.37%20.45%22.47%
EBIT Margin
104.46%-68.81%229.71%194.22%-1163.52%
EBITDA Margin
107.14%-63.04%244.72%213.83%398.64%
Operating Profit Margin
-76.63%-68.81%-86.54%-98.58%386.03%
Pretax Profit Margin
-406.14%-22.53%228.98%310.40%-1198.21%
Net Profit Margin
-406.14%92.48%228.98%302.16%-1049.54%
Continuous Operations Profit Margin
-406.14%92.48%228.98%310.40%-1047.19%
Net Income Per EBT
100.00%-410.49%100.00%97.34%87.59%
EBT Per EBIT
530.01%32.74%-264.59%-314.89%-310.39%
Return on Assets (ROA)
-14.11%3.64%9.91%12.46%-84.40%
Return on Equity (ROE)
-13.53%3.69%10.09%12.68%-114.63%
Return on Capital Employed (ROCE)
-2.76%-2.74%-3.79%-4.12%41.75%
Return on Invested Capital (ROIC)
-2.69%-2.73%-3.79%-4.27%36.15%
Return on Tangible Assets
-14.12%3.64%9.92%12.52%-84.70%
Earnings Yield
-883.36%5.53%17.29%20.21%-212.96%
Efficiency Ratios
Receivables Turnover
1.12 1.46 2.05 1.49 2.08
Payables Turnover
10.37 25.17 9.33 15.62 28.63
Inventory Turnover
0.00 229.57 57.47 5.66 5.77
Fixed Asset Turnover
0.00 0.00 5.94 2.41 3.09
Asset Turnover
0.03 0.04 0.04 0.04 0.08
Working Capital Turnover Ratio
2.18 1.19 0.85 -1.27 -0.35
Cash Conversion Cycle
289.60 236.36 144.93 285.67 226.34
Days of Sales Outstanding
324.81 249.28 177.72 244.60 175.84
Days of Inventory Outstanding
0.00 1.59 6.35 64.45 63.25
Days of Payables Outstanding
35.21 14.50 39.14 23.37 12.75
Operating Cycle
324.81 250.87 184.07 309.05 239.09
Cash Flow Ratios
Operating Cash Flow Per Share
-7.28K -552.97 -3.32 -105.16 -3.17K
Free Cash Flow Per Share
-7.29K -557.20 -11.76 -138.29 -3.26K
CapEx Per Share
8.21 4.23 8.44 33.13 91.20
Free Cash Flow to Operating Cash Flow
1.00 1.01 3.54 1.31 1.03
Dividend Paid and CapEx Coverage Ratio
-886.92 -130.67 -0.39 -3.17 -34.79
Capital Expenditure Coverage Ratio
-886.92 -130.67 -0.39 -3.17 -34.79
Operating Cash Flow Coverage Ratio
-0.90 -4.76 -0.04 -1.77 -6.48
Operating Cash Flow to Sales Ratio
-0.71 -0.88 >-0.01 -0.17 -1.01
Free Cash Flow Yield
-7.76%-5.31%-0.13%-1.48%-21.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-1.12 18.09 5.78 4.95 -0.47
Price-to-Sales (P/S) Ratio
9.16 16.73 13.25 14.95 4.93
Price-to-Book (P/B) Ratio
0.02 0.67 0.58 0.63 0.54
Price-to-Free Cash Flow (P/FCF) Ratio
-12.84 -18.83 -794.31 -67.54 -4.75
Price-to-Operating Cash Flow Ratio
-0.64 -18.97 -2.81K -88.81 -4.88
Price-to-Earnings Growth (PEG) Ratio
-0.02 -0.28 -0.40 -0.05 <0.01
Price-to-Fair Value
0.02 0.67 0.58 0.63 0.54
Enterprise Value Multiple
8.86 -26.61 5.13 6.58 1.07
Enterprise Value
48.64B 105.63B 88.44B 87.82B 48.69B
EV to EBITDA
8.90 -26.61 5.13 6.58 1.07
EV to Sales
9.53 16.77 12.56 14.07 4.27
EV to Free Cash Flow
-13.36 -18.87 -753.24 -63.56 -4.11
EV to Operating Cash Flow
-13.38 -19.02 -2.67K -83.58 -4.23
Tangible Book Value Per Share
283.22K 15.70K 15.99K 14.82K 28.66K
Shareholders’ Equity Per Share
283.44K 15.70K 16.01K 14.88K 28.80K
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.12
Revenue Per Share
10.22K 626.92 705.16 624.65 3.15K
Net Income Per Share
-41.52K 579.80 1.61K 1.89K -33.01K
Tax Burden
1.00 -4.10 1.00 0.97 0.88
Interest Burden
-3.89 0.33 1.00 1.60 1.03
Research & Development to Revenue
0.00 0.00 <0.01 <0.01 <0.01
SG&A to Revenue
0.35 0.28 0.37 0.47 0.37
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.18 3.91 >-0.01 -0.06 0.10
Currency in KRW